Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.CEB.2011.01.003 | ||||
| Año | 2011 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Several neurodegenerative diseases share common neuropathology, primarily featuring the presence in the brain of abnormal protein inclusions containing specific misfolded proteins. Recent evidence indicates that alteration in organelle function is a common pathological feature of protein misfolding disorders, highlighting perturbations in the homeostasis of the endoplasmic reticulum (ER). Signs of ER stress have been detected in most experimental models of neurological disorders and more recently in brain samples from human patients with neurodegenerative disease. To cope with ER stress, cells activate an integrated signaling response termed the unfolded protein response (UPR), which aims to reestablish homeostasis in part through regulation of genes involved in protein folding, quality control and degradation pathways. Here we discuss the particular mechanisms currently proposed to be involved in the generation of protein folding stress in different neurodegenerative conditions and speculate about possible therapeutic interventions.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | MATUS-MONTERO, MARIA SOLEDAD | Mujer |
Universidad de Chile - Chile
|
| 2 | Glimcher, Laurie H. | Mujer |
Harvard University - Estados Unidos
Harvard T.H. Chan School of Public Health - Estados Unidos Harvard Medical School - Estados Unidos |
| 3 | HETZ-FLORES, CLAUDIO ANDRES | Hombre |
Harvard University - Estados Unidos
Universidad de Chile - Chile Harvard T.H. Chan School of Public Health - Estados Unidos |
| Fuente |
|---|
| FONDECYT |
| CONICYT |
| FONDAP |
| National Institutes of Health |
| Millennium Nucleus |
| International Center for Genetic Engineering and Biotechnology |
| Alzheimer's Association |
| ICGEB |
| Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica |
| Fondo de Financiamiento de Centros de Investigación en Áreas Prioritarias |
| National Institute of Allergy and Infectious Diseases |
| Fondo Nacional de Desarrollo CientÃfico, Tecnológico y de Innovación Tecnológica |
| Genzyme |
| CHDI Foundation Inc |
| CHDI Foundation |
| Mathers Foundation |
| ALSA-The Milton Safenowitz Post-Doctoral Fellowship for ALS Research |
| M.J. Fox Foundation for Parkinson's Research |
| G. Harold and Leila Y. Mathers Charitable Foundation |
| Programa Atracción e Inserción de Capital Humano Avanzado CONICYT |
| Agradecimiento |
|---|
| This work was supported by FONDECYT (1100176), FONDAP (15010006), Millennium Nucleus (P07-048-F), CHDI Foundation Inc, Genzyme, Alzheimer's Association (NIRG-10-173294), M.J. Fox Foundation for Parkinson's Research, and ICGEB (CH); and ALSA-The Milton Safenowitz Post-Doctoral Fellowship for ALS Research 1829 and a fellowship from the Programa Atraccion e Insercion de Capital Human Avanzado CONICYT (79100007) (S.M.), and the National Institutes of Health (AI32412), a gift from the Mathers Foundation and a gift from an anonymous foundation (L.H.G.). |
| This work was supported by FONDECYT (1100176), FONDAP (15010006), Millennium Nucleus (P07-048-F), CHDI Foundation Inc, Genzyme, Alzheimer's Association (NIRG-10-173294), M.J. Fox Foundation for Parkinson's Research, and ICGEB (CH); and ALSA-The Milton Safenowitz Post-Doctoral Fellowship for ALS Research 1829 and a fellowship from the Programa Atracción e Inserción de Capital Humano Avanzado CONICYT (79100007) (S.M.), and the National Institutes of Health (AI32412), a gift from the Mathers Foundation and a gift from an anonymous foundation (L.H.G.). |